Abstract
In overviews of mammography trials and debates about mammography, at least one finding has been consistent: the mortality benefits of screening take longer to become apparent and the absolute benefits are smaller in women younger than age 50 years than in those age 50 years or older. The commentary by Dr. Baines proposes a novel partial explanation for this finding, arguing that screening and early surgery may actually increase breast cancer deaths in the short term for women with distant metastases while decreasing deaths in the long term for women whose disease is localized at time of detection. Although intriguing, this hypothesis is not well supported by the data presented. I write here on behalf of the United States Preventive Services Task Force (USPSTF), and my message is that, although we are skeptical of Dr. Baines’s claim, we agree with some of her conclusions about the clinical implications for younger women.

This publication has 2 references indexed in Scilit: